Kim Brunisholz, director of Population Health Research at Johnson & Johnson, is conducting research to bridge the gap between evidence-based care and its implementation in routine clinical practice. Overcoming the challenges of translating research into practice requires understanding patient-provider perspectives and using qualitative and quantitative methods to identify and address care gaps. This research can also identify root causes and barriers to care, enabling stakeholders to develop and implement interventions to improve patient care.

Kim explains, "My goal is really around how I impact the translation and implementation of evidence-based care into routine practice. What I'm looking to do is ensure that all patients have access to what we know works in medicine. So, there are a variety of questions that we may pursue in our research programs, mostly around how we might think around closing the evidence-to-practice gap for patients and bringing what we know works to them."

"It starts with the patient-provider relationship. And it's probably a lot harder than the public realizes around how we can actually deliver in healthcare, the standard of care. For example, there's a statistic from the early 2000s where we're seeing that it takes on average, about 17 years to translate research into practice. That takes a long time to get what we know works into the hospitals and the clinics and to the bedside."

"What's even worse is that not only does it take forever for that evidence to get to the frontline, but even when it does, what we're seeing is, on average, only about 14% of clinicians will actually adopt that innovation as standard of care. So that means over 80% of patients are getting that low-value care, potentially ineffective care. I think that's what shows up as poor outcomes for our patients."

#MultipleMyeloma #HealthEquity #PopulationHealth #SDOH #SocialDeterminantsofHealth #CancerCare

jnj.com

Download the transcript here